We’re halfway through 2026, and Microsoft SQL has not slowed down. Since SQLCon/FabCon in March (where we released a ton of things, and those updates can be found in this updates video), we shipped a ...
本文详解SQL中DATEDIFF函数在SQL Server、MySQL、PostgreSQL和SQLite四大主流数据库中的语法差异与行为特点，涵盖日期单位支持、参数顺序、精度处理等核心区别；介绍工作日计算、精确时间差及跨库 ...
Emese Zsiros, MD, PhD, FACOG, spoke about the newly approved pembrolizumab regimen in PD-L1–expressing, pretreated platinum-resistant gynecologic cancers. On February 10, 2026, the FDA approved ...
The folate receptor α ADC yielded responses, with a favorable safety profile, in patients with high-grade serous ovarian cancer in a phase 1 trial. The FDA has granted breakthrough therapy designation ...
DATEDIFF 函数在 SQL 中是一个用于计算两个日期之间差值的重要工具。不同数据库实现了不同版本的 DATEDIFF，它们在功能和语法上有所不同。本文将详细解析 DATEDIFF 的用法、数据库间差异、复杂 ...
The IRS released guidance Thursday in Rev. Proc. 2025-28 advising taxpayers how to handle making various elections, filing amended returns, and changing accounting methods for research or experimental ...
Therapeutic advances across the gynecologic cancer continuum have resulted in improvements in patient care and outcomes over the past decade, yet challenges remain. In ovarian cancer, the evolution of ...
Biomarker results from the KGOG3056/NIRVANA-R trial: Maintenance niraparib plus bevacizumab in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results